Diamedica Therapeutics Inc (DMAC)

06:59 AM

Can machine learning forecast DiaMedica Therapeutics Inc. recoveryForecast Cut & Free Technical Pattern Based Buy Signals - Newser

06:59 AM

05:11 AM

Technical analysis overview for DiaMedica Therapeutics Inc. stockTrade Ideas & Daily Price Action Insights - Newser

05:11 AM

02:05 AM

Identifying reversal signals in DiaMedica Therapeutics Inc.2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser

02:05 AM

Aug 14, 2025

DiaMedica Therapeutics Inc (DMAC) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

Aug 14, 2025

Aug 14, 2025

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 14, 2025

Aug 14, 2025

Will DiaMedica Therapeutics Inc. see short term momentumEarnings Risk Report & Fast Entry High Yield Stock Tips - Newser

Aug 14, 2025

Aug 14, 2025

DiaMedica advances DM199 programs with $60M cash runway and expanded clinical trials - MSN

Aug 14, 2025

Aug 14, 2025

Statistical indicators supporting DiaMedica Therapeutics Inc.’s strengthIPO Watch & Target Return Focused Stock Picks - Newser

Aug 14, 2025

Aug 14, 2025

DiaMedica Therapeutics Advances with Positive Trials and Funding - TipRanks

Aug 14, 2025

Aug 13, 2025

Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedShare Buyback & Real-Time Buy Signal Notifications - Newser

Aug 13, 2025

Aug 13, 2025

DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c) - MSN

Aug 13, 2025

Aug 13, 2025

DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia (NASDAQ:DMAC) - Seeking Alpha

Aug 13, 2025

Aug 13, 2025

Diamedica Therapeutics shares rise 14.94% intraday after Celcuity's positive Phase 3 trial results. - AInvest

Aug 13, 2025

Aug 13, 2025

DiaMedica Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 13, 2025

Aug 13, 2025

Diamedica Therapeutics shares rise 1.92% intraday after Q2 2025 earnings call. - AInvest

Aug 13, 2025

Aug 13, 2025

Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials By Investing.com - Investing.com South Africa

Aug 13, 2025

Aug 13, 2025

Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials - Investing.com India

Aug 13, 2025

Aug 13, 2025

What to expect from DiaMedica Therapeutics Inc. in the next 30 daysWeekly Market Summary & Expert Approved Momentum Ideas - Newser

Aug 13, 2025

Aug 13, 2025

Pattern recognition hints at DiaMedica Therapeutics Inc. upside2025 Trade Ideas & Fast Gain Stock Tips - Newser

Aug 13, 2025

Aug 13, 2025

Technical signs of recovery in DiaMedica Therapeutics Inc.Weekly Investment Report & Free Reliable Trade Execution Plans - Newser

Aug 13, 2025

Aug 13, 2025

DiaMedica Posts Narrower Loss in Q2 - AOL.com

Aug 13, 2025

Aug 13, 2025

What indicators show strength in DiaMedica Therapeutics Inc. [Short Setup]Weekly Top Gainers Trade List - Newser

Aug 13, 2025

Aug 12, 2025

DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - BioSpace

Aug 12, 2025

Aug 12, 2025

Full technical analysis of DiaMedica Therapeutics Inc. stockAI Intraday Market Movement Prediction Tool - Newser

Aug 12, 2025

Aug 12, 2025

DiaMedica Therapeutics Enters Sales Agreement with TD Securities - TipRanks

Aug 12, 2025

Aug 12, 2025

Is this a good reentry point in DiaMedica Therapeutics Inc.Fast Entry Strategy with Price Prediction - Newser

Aug 12, 2025

Aug 12, 2025

DiaMedica Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2025

Aug 12, 2025

Can DiaMedica Therapeutics Inc. sustain its profitabilityReal-Time Trade Breakout Scanner - thegnnews.com

Aug 12, 2025

Aug 12, 2025

Screener Results Flag DiaMedica Therapeutics Inc. as OversoldROI Driven Equity Selection With Safety Emphasized - 선데이타임즈

Aug 12, 2025

Aug 12, 2025

What data driven models say about DiaMedica Therapeutics Inc.’s futureRapid Trade Forecast Based on Indicators - Newser

Aug 12, 2025

Aug 11, 2025

Momentum divergence signals in DiaMedica Therapeutics Inc. chartAutomated AI Forecast with Trading Alerts - Newser

Aug 11, 2025

Aug 11, 2025

Fair Value Estimate for DiaMedica Therapeutics: $5.11; Share Price Matches Fair Value; Analyst Price Target Exceeds Fair Value. - AInvest

Aug 11, 2025

Aug 10, 2025

Volume spikes in DiaMedica Therapeutics Inc. stock – what they meanShort-Term AI-Based Stock Price Forecast - Newser

Aug 10, 2025

Aug 10, 2025

What’s the recovery path for long term holders of DiaMedica Therapeutics Inc. - Newser

Aug 10, 2025

Aug 10, 2025

What makes DiaMedica Therapeutics Inc. stock price move sharplyFree AI Based High Gain Watchlist Scanner - Newser

Aug 10, 2025

Aug 10, 2025

Press Release: DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - 富途牛牛

Aug 10, 2025

Aug 09, 2025

Can momentum traders help lift DiaMedica Therapeutics Inc.Free Low Risk Buy Zone Opportunity Watch - Newser

Aug 09, 2025

Aug 08, 2025

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 08, 2025

What indicators show strength in DiaMedica Therapeutics Inc.Conservative Equity Setup with Signal Analysis - Newser

Aug 08, 2025

Aug 07, 2025

DiaMedica Therapeutics appoints Julie Krop as Chief Medical Officer - MSN

Aug 07, 2025

Aug 07, 2025

DiaMedica Appoints New Chief Medical Officer - The Globe and Mail

Aug 07, 2025

Aug 06, 2025

Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Swing Entry Insight With Forecast Accuracy - Newser

Aug 06, 2025

Aug 06, 2025

Diamedica Therapeutics shares rise 3.12% intraday after appointing Julie Krop, MD, as Chief Medical Officer. - AInvest

Aug 06, 2025